Strickland J E, Ueda M, Hennings H, Yuspa S H
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892.
Cancer Res. 1992 Mar 15;52(6):1439-44.
The availability of a skin grafting system on nude mouse hosts and of epidermal cell lines which form papillomas when grafted has made possible the creation of a model for initiated skin in vivo from cultured cells. When grafted with 6-8 x 10(6) primary dermal fibroblasts, 10 x 10(6) primary epidermal cells form an apparently normal skin, and cell line SP-1 (0.5 x 10(6) cells) forms papillomas. Cell line SP-1 was derived from papillomas produced on SENCAR mice by initiation with 7,12-dimethylbenzaadaa]anthracene and promotion with 12-O-tetradecanoylphorbol-13-acetate. Grafting of 0.5 x 10(6) SP-1 cells along with 10 x 10(6) SENCAR newborn primary epidermal cells resulted in a 90% reduction in the average papilloma volume per mouse compared to controls without primary epidermal cells. Suppression occurred specifically with epidermal cells, either cultured or freshly prepared, and was not seen when an equivalent number of SENCAR primary dermal fibroblasts was grafted in place of epidermal cells. Nor did suppression occur when primary epidermal cells were replaced with a carcinogen-altered cell line, SCR722. SCR722 cells have a normal-skin phenotype when grafted. Furthermore, suppression of tumor formation did not occur when a malignant variant of SP-1 cells replaced benign SP-1 cells in grafts. Repeated treatment of suppressed grafts with 12-O-tetradecanoylphorbol-13-acetate resulted in an increased number of mice with papillomas and a larger mean papilloma volume per mouse compared to controls treated with solvent alone, whereas treatment of nonsuppressed grafts of papilloma cells with promoter produced no change in tumor size. These results support the concepts that normal epidermal cells suppress the growth of initiated cells and that repeated treatment with phorbol ester tumor promoters overcomes the suppression, leading to benign tumor formation.
在裸鼠宿主上具备皮肤移植系统以及移植时会形成乳头瘤的表皮细胞系,使得从培养细胞在体内创建起始皮肤模型成为可能。当与6 - 8×10⁶原代真皮成纤维细胞一起移植时,10×10⁶原代表皮细胞形成外观正常的皮肤,而细胞系SP - 1(0.5×10⁶个细胞)则形成乳头瘤。细胞系SP - 1源自用7,12 - 二甲基苯并[a]蒽引发并以12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯促进在SENCAR小鼠上产生的乳头瘤。与没有原代表皮细胞的对照组相比,将0.5×10⁶个SP - 1细胞与10×10⁶个SENCAR新生原代表皮细胞一起移植,使每只小鼠的平均乳头瘤体积减少了90%。这种抑制作用特异性地发生在培养的或新鲜制备的表皮细胞上,当移植等量的SENCAR原代真皮成纤维细胞代替表皮细胞时未观察到这种抑制作用。当原代表皮细胞被致癌物改变的细胞系SCR722替代时,也未发生抑制作用。SCR722细胞移植时具有正常皮肤表型。此外,当移植中SP - 1细胞的恶性变体替代良性SP - 1细胞时,未发生肿瘤形成的抑制作用。与仅用溶剂处理的对照组相比,用12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯反复处理受抑制的移植体导致出现乳头瘤的小鼠数量增加,且每只小鼠的平均乳头瘤体积更大,而用启动子处理乳头瘤细胞的未受抑制移植体则肿瘤大小无变化。这些结果支持了以下概念:正常表皮细胞抑制起始细胞的生长,并且用佛波酯肿瘤启动子反复处理可克服这种抑制作用,导致良性肿瘤形成。